United States · FDA National Drug Code directory

GEMTESA

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
73336-075_6744a1cf-7abb-4623-85e3-8f67a9eb19d4
Product NDC
73336-075
Form
TABLET, FILM COATED
Composition / generic term
vibegron
Labeler
Sumitomo Pharma America, Inc.
Marketing category
NDA
Marketing start / end (source format)
20201229
Source listing expiry
20261231

Source-listed ingredients

  • VIBEGRON — 75 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BOTTLE in 1 CARTON (73336-075-07) / 7 TABLET, FILM COATED in 1 BOTTLE · 73336-075-07
  • 30 TABLET, FILM COATED in 1 BOTTLE (73336-075-30) · 73336-075-30
  • 90 TABLET, FILM COATED in 1 BOTTLE (73336-075-90) · 73336-075-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →